Guan Wang
Impact in
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Angiogenesis and VEGF in Cancer
- Pluripotent Stem Cells Research
- Oncology top 5%
- CAR-T cell therapy research
Papers in
-
- Protein Degradation and Inhibitors 12
- Protein Kinase Regulation and GTPase Signaling 7
- Oncology 20
- Co-authors
- Liang Ouyang (52 shared papers)Kenneth A. Thomas (1 shared paper)Richard L. Kendall (1 shared paper)Junping Pei (10 shared papers)Lan Zhang (11 shared papers)Jifa Zhang (10 shared papers)Yu Sun (1 shared paper)Yuan Liu (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (22 papers)European Journal of Medicinal Chemistry (16 papers)Acta Pharmaceutica Sinica B (7 papers)Bioorganic Chemistry (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Guan Wang
217 papers receiving 7.5k citations
Guan Wang's Hit Papers
Peers
Comparison fields: 5 of 161
- Molecular Biology 2.3k
- Oncology 809
- Genetics 214
- Pulmonary and Respiratory Medicine 689
- Geriatrics and Gerontology 75
Countries citing papers authored by Guan Wang
This map shows the geographic impact of Guan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Wang more than expected).
Fields of papers citing papers by Guan Wang
This network shows the impact of papers produced by Guan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Wang. The network helps show where Guan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 626 | |
| 2 | 2019 | 376 | |
| 3 | Chemical reprogramming of human somatic cells to pluripotent stem cells Hit paper breakdown → | 2022 | 287 |
| 4 | 2017 | 229 | |
| 5 | ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage Hit paper breakdown → | 2022 | 221 |
| 6 | 2021 | 217 | |
| 7 | 2017 | 178 | |
| 8 | 2022 | 125 | |
| 9 | 2021 | 119 | |
| 10 | 2020 | 118 | |
| 11 | 2020 | 118 | |
| 12 | 2021 | 118 | |
| 13 | 2021 | 113 | |
| 14 | 2011 | 111 | |
| 15 | 2022 | 108 | |
| 16 | 2021 | 102 | |
| 17 | 2023 | 102 | |
| 18 | 2020 | 101 | |
| 19 | 2019 | 100 | |
| 20 | 2013 | 89 |
About Guan Wang
Guan Wang is a scholar working on Molecular Biology, Oncology, Pharmacology, Neurology and Organic Chemistry, having authored 224 papers that have together received 7.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (14 papers), Protein Degradation and Inhibitors (12 papers), Computational Drug Discovery Methods (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers), Lung Cancer Treatments and Mutations (10 papers), Autophagy in Disease and Therapy (9 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Advancements in Battery Materials (7 papers). The work is most often cited by research in Molecular Biology (2.3k citations), Oncology (809 citations), Genetics (214 citations), Pulmonary and Respiratory Medicine (689 citations) and Geriatrics and Gerontology (75 citations). Guan Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Liang Ouyang, Kenneth A. Thomas, Richard L. Kendall, Junping Pei, Lan Zhang, Jifa Zhang, Yu Sun, Yuan Liu, Haiyan Zhang and Shuai Wen. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B, Bioorganic Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.